Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Filed Jan 29, 2013 · 10-K · 90 days after period end · 0001493152-13-000132
derived · Computed from the longer spans the company filed.
| Metric | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|---|
| Net Income | -$1.04K | -$1.72K | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
ended Oct 31, 2012 · filed Jan 29, 2013 · 90 d after period end
